Dr. Zoubeidi awarded Canada Research Chair 1 in Cancer Therapy Resistance

Date Posted: 
Dr. Amina Zoubeidi

Congratulations to Dr. Amina Zoubeidi on being awarded the Canada Research Chair 1 in Cancer Therapy Resistance.

Dr. Zoubeidi’s research program aims to provide mechanistic insight into the molecular (genetic and epigenetic) sources that fuel tumour cell plasticity and emergent resistance phenotypes following targeted therapy. She leverages this information this knowledge to identify early detection biomarkers and nominate new targets to block the mechanisms utilized by tumour cells to gain access to cell plasticity that can be used alone or in combination to improve the efficacy of existing therapies and patient outcomes. Importantly, as lineage reprogramming is emerging as a conserved mechanism of resistance across tumour types, results from this program may have relevance in other highly prevalent cancers, such as melanoma and lung and breast cancer.

Dr. Zoubeidi is a Professor at the Department of Urologic Sciences and Senior Scientist at the Vancouver Prostate Centre. She is Michael Smith Scholar, who received multiple awards including PCF Challenge Award, UBC Faculty of Medicine Distinguished Achievement Awards for Overall Excellence-Early Career (2014) and for Excellence in Basic Science (2018), and three Teaching Awards for Excellence in Basic Science, Department of Urologic Sciences, Faculty of Medicine, University of British Columbia (2014, 2017 & 2018).

Dr. Zoubeidi has been awarded a number of prestigious grants, including a Prostate Cancer Canada Translation Acceleration Grant, US Prostate Cancer Foundation Challenge award, and numerous Canadian Institute of Health Research awards and Terry Fox Research Institute awards. 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


Conference Flyer Page 1

Breast & Prostate Cancer half-day virtual conference: Saturday, September 18th, 2021

The What you Need to Know for Your Patients Post Breast & Prostate Cancer Conference, taking place online on Saturday, September 18th, 2021 from 8:00am – 1:30pm, is an accredited virtual half-day conference focusing on screening, treatment, side-effect management & emerging new therapies for breast & prostate cancer patients. Click here for more information and to register. 

Dr. Peter Black, team captain

Terry Fox Run fundraiser: September 19th, 2021

The 41st Annual Terry Fox Run is taking place on Sunday September 19, 2021. If you are able, please consider donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research. 


Work at the Vancouver Prostate Centre

Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer

Tuesday, August 3, 2021

Dr. Cherkasov receives 2021 Faculty of Medicine Distinguished Achievement Award

Dr. Cherkasov